The board of directors of Biolidics Limited announced the following: Mr. Chen Johnson ("Mr Chen"), the founder of the Company, has tendered his resignation as the Non-Executive Non-Independent Director of the Company, with his effective cessation date being 1 February 2023. Consequently, Mr. Chen will cease to be a member of the nominating committee (NC) of the company with effect from 1 February 2023. Following Mr. Chen's cessation as a member of the NC, Mr. Gavin Mark Mcintyre, the Non-Executive Independent Chairman of the Company, will be appointed as a member of the NC with effect from 1 February 2023.

Consequent to the above referred changes, the composition of the Board and the NC are as follows: Board: Mr. Gavin Mark McIntyre-Non-Executive Independent Chairman, Mr. Song Tang Yih-Executive Director and Chief Executive Officer, Mr. Chia Beng Kwan-Independent Director, Mr. Ian David Brown-Independent Director. Nominating Committee: Mr. Chia Beng Kwan-Chairman, Mr. Gavin Mark McIntyre-Member, Mr. Ian David Brown-Member, The composition of the audit committee and the remuneration committee of the Company remains unchanged as follow: Audit Committee: Mr. Gavin Mark McIntyre-Chairman, Mr. Chia Beng Kwan-Member, Mr. Ian David Brown-Member. Remuneration Committee: Mr. Ian David Brown-Chairman, Mr. Chia Beng Kwan-Member, Mr. Gavin Mark McIntyre-Member.